138 related articles for article (PubMed ID: 32791397)
1. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.
Qiu J; Zhou Q; Zhang Y; Guan M; Li X; Zou Y; Huang X; Zhao Y; Chen W; Gu X
Eur J Med Chem; 2020 Nov; 205():112581. PubMed ID: 32791397
[TBL] [Abstract][Full Text] [Related]
2. Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors.
Qiu J; Chen W; Zhang Y; Zhou Q; Chen J; Yang L; Gao J; Gu X; Tang D
Eur J Med Chem; 2019 Aug; 176():41-49. PubMed ID: 31091479
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of Novel Quinazolinone Derivatives as Potential Anti-HCC Agents.
Qiu J; Zou Y; Liu Q; Jiang C; Zhou Q; Li S; Chen W; Li Z; Gu X
Chem Biodivers; 2022 Feb; 19(2):e202100766. PubMed ID: 34862731
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.
Qiu J; Zhou Q; Zou Y; Li S; Yang L; Chen W; Gao J; Gu X
Eur J Med Chem; 2022 Mar; 231():114159. PubMed ID: 35123297
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.
Gu X; Zhang Y; Zou Y; Li X; Guan M; Zhou Q; Qiu J
Bioorg Med Chem; 2021 Jan; 29():115892. PubMed ID: 33285406
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
9. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
10. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
11. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
13. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
14. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.
Liu X; Xu Z; Hou C; Wang M; Chen X; Lin Q; Song R; Lou M; Zhu L; Qiu Y; Chen Z; Yang C; Zhu W; Shao J
Biochem Pharmacol; 2016 Mar; 103():118-28. PubMed ID: 26774458
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
[TBL] [Abstract][Full Text] [Related]
17. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M
Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents.
Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH
Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891
[TBL] [Abstract][Full Text] [Related]
20. 2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly.
Zhu X; Zhao G; Zhou X; Xu X; Xia G; Zheng Z; Wang L; Yang X; Li S
Bioorg Med Chem Lett; 2010 Jan; 20(1):299-301. PubMed ID: 19897363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
